The lancet. Gastroenterology & hepatology, 7(9), 830-842. HANLEY & BELFUS-ELSEVIER INC Thompson, R J, Arnell, H, Artan, R, Baumann, U, Calvo, P L, Czubkowski, P, Dalgic, B, D'Antiga, L, Durmaz, Ö, Fischler, B, Gonzalès, E, Grammatikopoulos, T, Gupte, G, Hardikar, W, Houwen, R H J, Kamath, B M, Karpen, S J, Kjems, L, Lacaille, F, Lachaux, A, Lainka, E, Mack, C L, Mattsson, J P, McKiernan, P, Özen, H, Rajwal, S R, Roquelaure, B, Shagrani, M, Shteyer, E, Soufi, N, Sturm, E, Tessier, M E, Verkade, H J & Horn, P 2022, ' Odevixibat treatment in progressive familial intrahepatic cholestasis : a randomised, placebo-controlled, phase 3 trial ', The Lancet Gastroenterology & Hepatology . https://doi.org/10.1016/S2468-1253(22)00093-0
Journal of Pediatric Gastroenterology and Nutrition Journal of Pediatric Gastroenterology and Nutrition, 2021, 72 (6), pp.826-832. ⟨10.1097/MPG.0000000000003049⟩ Journal of Pediatric Gastroenterology and Nutrition, Lippincott, Williams & Wilkins, 2021, 72 (6), pp.826-832. ⟨10.1097/MPG.0000000000003049⟩